Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis

Summary

This study is to evaluate non inferiority of Eurofarma budesonide nasal spray x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will receive Astrazeneca medication. There is no placebo group.

Timeline

Start

2019-10-08

Primary completion

2019-10-08

Completion

2019-10-08

Outcome

Outcome not reported

Stopped (Business): “regulatory strategy”

Drugs

Indications